Ustekinumab (STELARA) for the Treatment of Active Sight-Threatening Uveitis (STAR Study)
Clinical trial NCT02911116 · COMPLETED
Trial details
- NCT number
- NCT02911116
- Sponsor
- National Eye Institute (NEI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2020-03-05
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.